Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer
about
Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer
description
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Osteopontin promotes cancer ce ...... ced non-small-cell lung cancer
@en
Osteopontin promotes cancer ce ...... ced non-small-cell lung cancer
@nl
type
label
Osteopontin promotes cancer ce ...... ced non-small-cell lung cancer
@en
Osteopontin promotes cancer ce ...... ced non-small-cell lung cancer
@nl
prefLabel
Osteopontin promotes cancer ce ...... ced non-small-cell lung cancer
@en
Osteopontin promotes cancer ce ...... ced non-small-cell lung cancer
@nl
P2093
P2860
P356
P1476
Osteopontin promotes cancer ce ...... ced non-small-cell lung cancer
@en
P2093
Jianan Huang
Xiaoping Ouyang
Yumin Huang
P2860
P304
P356
10.2147/OTT.S164007
P407
P577
2018-01-01T00:00:00Z